Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tonkin

Showing results (211-220 of 338) with videos related to

Pageof 34
Sort By:
Circulation|October 18, 2000
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling ProjectF M Sacks, A M Tonkin, J Shepherd, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 2012
Challenges in blood pressure measurement in patients treated with maintenance hemodialysisMatthew A Roberts, Helen L Pilmore, Andrew M Tonkin, et al.
Obesity (Silver Spring, Md.)|December 19, 2009
Cut-points for waist circumference in Europids and South AsiansAdrian J Cameron, Richard A Sicree, Paul Z Zimmet, et al.
The Annals of Thoracic Surgery|May 1, 1996
Prediction of outcome after revascularization in patients with poor left ventricular functionR K Chan, J Raman, K J Lee, et al.
Nature Genetics|March 14, 2007
The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeastTobias F Menne, Beatriz Goyenechea, Nuria Sánchez-Puig, et al.
Journal of Hypertension|December 11, 2002
Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatinMalcolm J West, Harvey D White, R John Simes, et al.
American Journal of Hypertension|November 16, 2014
Prediction of cardiovascular and all-cause mortality at 10 years in the hypertensive aged populationQuan L Huynh, Christopher M Reid, Enayet K Chowdhury, et al.
Circulation|May 1, 1991
A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis GroupP L Thompson, P E Aylward, J Federman, et al.
Environmental Health Perspectives|March 21, 2015
Forest Fire Smoke Exposures and Out-of-Hospital Cardiac Arrests in Melbourne, Australia: A Case-Crossover StudyMartine Dennekamp, Lahn D Straney, Bircan Erbas, et al.
European Journal of Preventive Cardiology|October 31, 2021
Alcohol consumption and risks of cardiovascular disease and all-cause mortality in healthy older adultsJohannes T Neumann, Rosanne Freak-Poli, Suzanne G Orchard, et al.
Pageof 34

Showing results (211-220 of 338) with videos related to

Sort By:
Pageof 34
Circulation|October 18, 2000
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling ProjectF M Sacks, A M Tonkin, J Shepherd, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 2012
Challenges in blood pressure measurement in patients treated with maintenance hemodialysisMatthew A Roberts, Helen L Pilmore, Andrew M Tonkin, et al.
Obesity (Silver Spring, Md.)|December 19, 2009
Cut-points for waist circumference in Europids and South AsiansAdrian J Cameron, Richard A Sicree, Paul Z Zimmet, et al.
The Annals of Thoracic Surgery|May 1, 1996
Prediction of outcome after revascularization in patients with poor left ventricular functionR K Chan, J Raman, K J Lee, et al.
Nature Genetics|March 14, 2007
The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeastTobias F Menne, Beatriz Goyenechea, Nuria Sánchez-Puig, et al.
Journal of Hypertension|December 11, 2002
Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatinMalcolm J West, Harvey D White, R John Simes, et al.
American Journal of Hypertension|November 16, 2014
Prediction of cardiovascular and all-cause mortality at 10 years in the hypertensive aged populationQuan L Huynh, Christopher M Reid, Enayet K Chowdhury, et al.
Circulation|May 1, 1991
A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis GroupP L Thompson, P E Aylward, J Federman, et al.
Environmental Health Perspectives|March 21, 2015
Forest Fire Smoke Exposures and Out-of-Hospital Cardiac Arrests in Melbourne, Australia: A Case-Crossover StudyMartine Dennekamp, Lahn D Straney, Bircan Erbas, et al.
European Journal of Preventive Cardiology|October 31, 2021
Alcohol consumption and risks of cardiovascular disease and all-cause mortality in healthy older adultsJohannes T Neumann, Rosanne Freak-Poli, Suzanne G Orchard, et al.
Pageof 34